These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12544510)

  • 21. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
    J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.
    Fitzgerald SM; Goyal RK; Osborne WR; Roy JD; Wilson JW; Ferrell RE
    Hum Genet; 2006 Apr; 119(3):276-83. PubMed ID: 16446974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J; Marquez VE; Momparler RL
    Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
    Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.
    Gabor KM; Schermann G; Lautner-Csorba O; Rarosi F; Erdelyi DJ; Endreffy E; Berek K; Bartyik K; Bereczki C; Szalai C; Semsei AF
    Pediatr Blood Cancer; 2015 Apr; 62(4):622-8. PubMed ID: 25557962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
    Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Single-nucleotide polymorphisms of the cytidine deaminase gene in 53 children with acute leukemia].
    Yue LJ; Chen XW; Li CR
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):458-9. PubMed ID: 17880796
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM; Momparler RL
    Cancer Lett; 1999 Jan; 135(1):29-36. PubMed ID: 10077218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ara-C metabolism: implications for drug resistance and drug interactions.
    Chabner BA; Hande KR; Drake JC
    Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site directed mutagenesis as a tool to understand the catalytic mechanism of human cytidine deaminase.
    Vincenzetti S; Pucciarelli S; Carpi FM; Micozzi D; Polzonetti V; Natalini P; Santarelli I; Polidori P; Vita A
    Protein Pept Lett; 2013 May; 20(5):538-49. PubMed ID: 23033855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
    Grau JJ; Caballero M; Monzó M; Muñoz-García C; Domingo-Domenech J; Navarro A; Conill C; Campayo M; Bombí JA
    J Surg Oncol; 2008 Aug; 98(2):130-4. PubMed ID: 18537153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.
    Fanciullino R; Farnault L; Donnette M; Imbs DC; Roche C; Venton G; Berda-Haddad Y; Ivanov V; Ciccolini J; Ouafik L; Lacarelle B; Costello R
    Blood Adv; 2018 Mar; 2(5):462-469. PubMed ID: 29490977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.
    Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V
    Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.
    Lachmann N; Brennig S; Phaltane R; Flasshove M; Dilloo D; Moritz T
    Neoplasia; 2013 Mar; 15(3):239-48. PubMed ID: 23479503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on thermal stability of human cytidine deaminase.
    Vincenzetti S; Pucciarelli S; Mariani P; De Sanctis G; Polzonetti V; Natalini P; Vita A
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1037-42. PubMed ID: 18058532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53.
    Jordheim LP; Nguyen-Dumont T; Thomas X; Dumontet C; Tavtigian SV
    Drug Metab Dispos; 2008 Dec; 36(12):2419-23. PubMed ID: 18775979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
    Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
    Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
    Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prokaryotic-type cytidine deaminase from Arabidopsis thaliana gene expression and functional characterization.
    Faivre-Nitschke SE; Grienenberger JM; Gualberto JM
    Eur J Biochem; 1999 Aug; 263(3):896-903. PubMed ID: 10469156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.